FDA approves AChEI ALPHA-1062 for Alzheimer’s disease treatment

If all goes ac­cord­ing to plan, in­sitro could fi­nal­ly start test­ing its first drug in clin­i­cal tri­als in 2026, eight years af­ter Daphne Koller found­ed

Huawei’s FusionPower9000 features a fully decoupled architecture, with a power supply system in one container that can be deployed outdoors. Data centres are experiencing significant

The bounc­er is let­ting a pre­clin­i­cal biotech en­ter the IPO club Thurs­day night. Yes, the time­stamp is 2024. A pre­clin­i­cal Nas­daq of­fer­ing sounds like a